N. Alvarez

Updating the approaches to define susceptibility and resistance to anti-tuberculosis agents: implications for diagnosis and treatment

John L. Johnson, K. Dooley, V. Furió, 2022, European Respiratory Journal.

Whole-Genome Sequencing of Two Latin American–Mediterranean Extensively Drug-Resistant Mycobacterium tuberculosis Clinical Isolates from Medellín, Colombia

D. Haft, F. Rouzaud, J. Robledo, 2016, Genome Announcements.

Some Synonymous and Nonsynonymous gyrA Mutations in Mycobacterium tuberculosis Lead to Systematic False-Positive Fluoroquinolone Resistance Results with the Hain GenoType MTBDRsl Assays

J. Parkhill, B. D. de Jong, S. Niemann, 2017, Antimicrobial Agents and Chemotherapy.

Systematic interpretation of molecular beacon PCR for identifying rpoB mutations in Mycobacterium tuberculosis isolates with mixed resistant and susceptible bacteria

Robledo, J. McCormick, S. Fisher-Hoch, 2010 .

The Structural Modeling of the Interaction between Levofloxacin and the Mycobacterium tuberculosis Gyrase Catalytic Site Sheds Light on the Mechanisms of Fluoroquinolones Resistant Tuberculosis in Colombian Clinical Isolates

F. Rouzaud, G. Mejía, E. Zapata, 2014, BioMed research international.

Systematic interpretation of molecular beacon polymerase chain reaction for identifying rpoB mutations in Mycobacterium tuberculosis isolates with mixed resistant and susceptible bacteria.

J. McCormick, S. Fisher-Hoch, Andrea S Bordt, 2010, Diagnostic microbiology and infectious disease.